Investors & Media

Stockholder Tools

Presentations

Please check back for updates.

Upcoming Events

Please check back for updates.

Past Events

June 5 - June 7, 2024
Jefferies Global Healthcare Conference
May 21, 2024
Poster presentation at American Thoracic Society International Conference 2024: Baseline characteristics from the IMPAHCT trial of AV-101, inhaled imatinib, in subjects with pulmonary arterial hypertension
March 13, 2024
Jefferies Biotech on the Bay Miami Summit
March 5, 2024
TD Cowen 44th Annual Health Care Conference
February 7, 2024
Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
June 7, 2023 at 8:00 AM EDT
Jefferies Global Healthcare Conference
May 16, 2023
Poster presentation at 2023 ATS International Conference: The Influence of Route of Delivery and Formulation on the Pulmonary Pharmacokinetics of Imatinib in Nonclinical Species
March 8, 2023 at 10:30 AM EST
Cowen 43rd Annual Health Care Conference
October 18, 2022
Inhaled iMatinib for Pulmonary Arterial Hypertension Clinical Trial: Design of the IMPAHCT Phase 2b/3 Study
August 10, 2022
Wedbush PacGrow 2022 Healthcare Conference
August 8, 2022
BTIG Biotechnology Conference 2022
June 9, 2022 at 3:30 PM EDT
Jefferies Global Healthcare Conference
May 16, 2022
Poster presentation at 2022 ATS International Conference: A Phase 1 Single and Multiple Ascending Dose (SAD/MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AV-101, a Novel Inhaled Dry Powder Formulation of Imatinib
March 8, 2022 at 10:30 AM EST
Cowen 42nd Annual Health Care Conference
November 30, 2021
Aerovate Therapeutics at the 4th Annual ISI HealthCONx Conference
November 18, 2021
Aerovate Therapeutics at the 2021 Jefferies London Healthcare Conference
August 11, 2021
Aerovate Therapeutics at the 2021 Wedbush PacGrow Healthcare Conference